Ambalal Sarabhai Enterprises Limited Share Price & Analysis
₹31.48▲ +0.87%Updated 7 May 2026, 11:32 am IST
LTP
₹31.48
+0.87%
Open
₹—
High
₹31.99
Low
₹30.96
Close
₹31.48
52W High
₹40.4
52W Low
₹23.1
Volume
23K
Lot Size
1
Sector
Healthcare
Market Cap
₹243 Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
13.7
Sector P/E
39.9
P/B
1.64
EPS
₹1.43
ROE
6.25%
ROCE
9.12%
D/E Ratio
0.32
Div Yield
0%
Book Value
₹19.2
+
Strengths
- ✓Attractively valued vs sector (P/E 13.7x vs industry 39.9x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,836 | ₹4.3L Cr | 35.8 | 5.67 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,696 | ₹1.7L Cr | 68.1 | 11.52 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,391 | ₹1.4L Cr | 61.4 | 17.56 | 26.5 | 27 | 0.33 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,301 | ₹1.1L Cr | 19.8 | 3.01 | 18 | 22.7 | 0.16 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹7,757 | ₹1.1L Cr | 60.5 | 12.27 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,369 | ₹1.1L Cr | 22.2 | 3.36 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,463 | ₹1.1L Cr | 21.2 | 5.73 | 20.6 | 21.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
AMBALALSA · as of Mar 2026
Promoters31.35%
FII0.38%
DII0.10%
Public68.18%▼0.36
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 30.78% | 30.78% | 30.78% | 31.35% | 31.35% | 31.35% |
| FII | — | — | — | — | — | 0.38% |
| DII | — | — | — | — | 0.10% | 0.10% |
| Public | 69.21% | 69.23% | 69.22% | 68.65% | 68.54% | 68.18% |
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹52 Cr ▲17.0% | ₹44.45 Cr ▲10.2% | ₹40.34 Cr ▼37.8% | ₹64.81 Cr ▲41.0% | ₹45.97 Cr ▲2.8% | ₹44.7 Cr ▲9.8% | ₹40.7 Cr ▼25.1% | ₹54.35 Cr |
| Op. Profit | ₹4.08 Cr ▲1033.3% | ₹0.36 Cr ▼75.3% | ₹1.46 Cr ▼72.5% | ₹5.3 Cr ▲857.1% | ₹-0.7 Cr ▼127.6% | ₹2.54 Cr ▲440.4% | ₹0.47 Cr ▼89.9% | ₹4.65 Cr |
| OPM | 7.8% ▲869.1% | 0.8% ▼77.6% | 3.6% ▼55.7% | 8.2% ▲638.2% | -1.5% ▼126.8% | 5.7% ▲393.9% | 1.1% ▼86.6% | 8.6% |
| Net Profit | ₹3.64 Cr ▲750.0% | ₹-0.56 Cr ▼106.8% | ₹8.22 Cr ▲3144.4% | ₹-0.27 Cr ▼112.1% | ₹2.23 Cr ▼14.9% | ₹2.62 Cr ▲648.6% | ₹0.35 Cr ▼96.1% | ₹9.02 Cr |
| EPS (₹) | 0.47 ▲771.4% | -0.07 ▼106.5% | 1.07 ▲2775.0% | -0.04 ▼113.8% | 0.29 ▼14.7% | 0.34 ▲580.0% | 0.05 ▼95.8% | 1.18 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹196 Cr ▲13.3% | ₹173 Cr ▲1.8% | ₹170 Cr ▼13.7% | ₹197 Cr ▲20.9% | ₹163 Cr ▲22.6% | ₹133 Cr ▼11.3% | ₹150 Cr ▲20.0% | ₹125 Cr ▼6.7% | ₹134 Cr |
| Expenses | ₹187 Cr ▲12.0% | ₹167 Cr ▲3.1% | ₹162 Cr ▼5.3% | ₹171 Cr ▲3.6% | ₹165 Cr ▲21.3% | ₹136 Cr ▼5.6% | ₹144 Cr ▲5.1% | ₹137 Cr ▲0.0% | ₹137 Cr |
| Op. Profit | ₹9 Cr ▲50.0% | ₹6 Cr ▼25.0% | ₹8 Cr ▼68.0% | ₹25 Cr ▲1350.0% | ₹-2 Cr ▲33.3% | ₹-3 Cr ▼150.0% | ₹6 Cr ▲150.0% | ₹-12 Cr ▼300.0% | ₹-3 Cr |
| OPM | 5.0% ▲66.7% | 3.0% ▼40.0% | 5.0% ▼61.5% | 13.0% ▲1400.0% | -1.0% ▲50.0% | -2.0% ▼150.0% | 4.0% ▲144.4% | -9.0% ▼350.0% | -2.0% |
| Other Income | ₹5 Cr ▼50.0% | ₹10 Cr ▼16.7% | ₹12 Cr ▼63.6% | ₹33 Cr ▼17.5% | ₹40 Cr ▲66.7% | ₹24 Cr ▲200.0% | ₹8 Cr ▼68.0% | ₹25 Cr ▲1350.0% | ₹-2 Cr |
| Interest | ₹5 Cr ▼16.7% | ₹6 Cr ▲100.0% | ₹3 Cr ▲50.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▼25.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲0.0% | ₹3 Cr ▼40.0% | ₹5 Cr |
| Depreciation | ₹4 Cr ▲0.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▼50.0% | ₹4 Cr |
| PBT | ₹5 Cr ▼28.6% | ₹7 Cr ▼53.3% | ₹15 Cr ▼72.2% | ₹54 Cr ▲63.6% | ₹33 Cr ▲120.0% | ₹15 Cr ▲87.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▲157.1% | ₹-14 Cr |
| Tax % | -2.0% ▼113.3% | 15.0% ▼40.0% | 25.0% ▲92.3% | 13.0% ▲30.0% | 10.0% ▲66.7% | 6.0% ▼87.5% | 48.0% ▼42.9% | 84.0% ▲147.1% | 34.0% |
| Net Profit | ₹5 Cr ▼16.7% | ₹6 Cr ▼45.5% | ₹11 Cr ▼76.6% | ₹47 Cr ▲62.1% | ₹29 Cr ▲107.1% | ₹14 Cr ▲250.0% | ₹4 Cr ▲300.0% | ₹1 Cr ▲105.6% | ₹-18 Cr |
| EPS (₹) | 0.64 ▼13.5% | 0.74 ▼50.3% | 1.49 ▼75.8% | 6.16 ▲60.8% | 3.83 ▲109.3% | 1.83 ▲232.7% | 0.55 ▲223.5% | 0.17 ▲107.1% | -2.38 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr |
| Reserves | ₹71 Cr ▲12.7% | ₹63 Cr ▲5.0% | ₹60 Cr ▲11.1% | ₹54 Cr ▲25.6% | ₹43 Cr ▲1533.3% | ₹-3 Cr ▲90.6% | ₹-32 Cr ▲30.4% | ₹-46 Cr ▲8.0% | ₹-50 Cr ▲2.0% | ₹-51 Cr |
| Borrowings | ₹47 Cr ▼7.8% | ₹51 Cr ▲10.9% | ₹46 Cr ▲2.2% | ₹45 Cr ▲66.7% | ₹27 Cr ▼3.6% | ₹28 Cr ▼9.7% | ₹31 Cr ▼22.5% | ₹40 Cr ▼7.0% | ₹43 Cr ▲2.4% | ₹42 Cr |
| Other Liabilities | ₹66 Cr ▼16.5% | ₹79 Cr ▲17.9% | ₹67 Cr ▼4.3% | ₹70 Cr ▼16.7% | ₹84 Cr ▼22.2% | ₹108 Cr ▼2.7% | ₹111 Cr ▼22.9% | ₹144 Cr ▲12.5% | ₹128 Cr ▲37.6% | ₹93 Cr |
| Total Liabilities | ₹260 Cr ▼3.7% | ₹270 Cr ▲8.0% | ₹250 Cr ▲1.6% | ₹246 Cr ▲6.5% | ₹231 Cr ▲10.0% | ₹210 Cr ▲12.9% | ₹186 Cr ▼13.1% | ₹214 Cr ▲8.6% | ₹197 Cr ▲23.1% | ₹160 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹87 Cr ▲0.0% | ₹87 Cr ▼1.1% | ₹88 Cr ▲3.5% | ₹85 Cr ▲46.6% | ₹58 Cr ▲1.8% | ₹57 Cr ▲0.0% | ₹57 Cr ▼1.7% | ₹58 Cr ▼1.7% | ₹59 Cr ▼18.1% | ₹72 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹4 Cr ▼66.7% | ₹12 Cr ▲1100.0% | ₹1 Cr | ₹0 Cr ▼100.0% | ₹24 Cr ▲71.4% | ₹14 Cr ▲366.7% | ₹3 Cr |
| Investments | ₹32 Cr ▲0.0% | ₹32 Cr ▲10.3% | ₹29 Cr ▼9.4% | ₹32 Cr ▼3.0% | ₹33 Cr ▲22.2% | ₹27 Cr ▲50.0% | ₹18 Cr ▲100.0% | ₹9 Cr ▲80.0% | ₹5 Cr ▲0.0% | ₹5 Cr |
| Other Assets | ₹141 Cr ▼6.6% | ₹151 Cr ▲13.5% | ₹133 Cr ▲6.4% | ₹125 Cr ▼2.3% | ₹128 Cr ▲2.4% | ₹125 Cr ▲13.6% | ₹110 Cr ▼10.6% | ₹123 Cr ▲3.4% | ₹119 Cr ▲48.8% | ₹80 Cr |
| Total Assets | ₹260 Cr ▼3.7% | ₹270 Cr ▲8.0% | ₹250 Cr ▲1.6% | ₹246 Cr ▲6.5% | ₹231 Cr ▲10.0% | ₹210 Cr ▲12.9% | ₹186 Cr ▼13.1% | ₹214 Cr ▲8.6% | ₹197 Cr ▲23.1% | ₹160 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹-18 Cr ▼300.0% | ₹9 Cr ▲50.0% | ₹6 Cr ▼45.5% | ₹11 Cr ▲650.0% | ₹-2 Cr ▲71.4% | ₹-7 Cr ▼136.8% | ₹19 Cr ▲371.4% | ₹-7 Cr ▼240.0% | ₹5 Cr ▲106.7% | ₹-75 Cr |
| Investing CF | ₹13 Cr ▲360.0% | ₹-5 Cr ▲70.6% | ₹-17 Cr ▼440.0% | ₹5 Cr ▼50.0% | ₹10 Cr ▼41.2% | ₹17 Cr ▲288.9% | ₹-9 Cr ▼150.0% | ₹18 Cr ▲700.0% | ₹-3 Cr ▼103.8% | ₹80 Cr |
| Financing CF | ₹-2 Cr ▲33.3% | ₹-3 Cr ▼133.3% | ₹9 Cr ▲147.4% | ₹-19 Cr ▼216.7% | ₹-6 Cr ▲57.1% | ₹-14 Cr ▼133.3% | ₹-6 Cr ▼200.0% | ₹-2 Cr ▲66.7% | ₹-6 Cr ▼100.0% | ₹-3 Cr |
| Net Cash Flow | ₹-6 Cr ▼700.0% | ₹1 Cr ▲150.0% | ₹-2 Cr ▲33.3% | ₹-3 Cr ▼250.0% | ₹2 Cr ▲150.0% | ₹-4 Cr ▼233.3% | ₹3 Cr ▼62.5% | ₹8 Cr ▲300.0% | ₹-4 Cr ▼300.0% | ₹2 Cr |
| Free Cash Flow | ₹-20 Cr ▼433.3% | ₹6 Cr ▲140.0% | ₹-15 Cr ▼193.8% | ₹16 Cr ▲128.6% | ₹7 Cr ▲170.0% | ₹-10 Cr ▼211.1% | ₹9 Cr ▲12.5% | ₹8 Cr ▲700.0% | ₹1 Cr ▼91.7% | ₹12 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82d ▲49.1% | 55d ▼6.8% | 59d ▲13.5% | 52d ▼40.2% | 87d ▲10.1% | 79d ▼6.0% | 84d ▼16.0% | 100d ▲26.6% | 79d ▼4.8% | 83d |
| Inventory Days | 75d ▲29.3% | 58d ▼6.5% | 62d ▲29.2% | 48d ▼17.2% | 58d ▼23.7% | 76d ▲24.6% | 61d ▼18.7% | 75d ▲13.6% | 66d ▼8.3% | 72d |
| Days Payable | 158d ▲18.8% | 133d ▲1.5% | 131d ▼13.2% | 151d ▼17.9% | 184d ▲0.0% | 184d ▼3.7% | 191d ▼7.7% | 207d ▲50.0% | 138d ▲2.2% | 135d |
| Cash Conv. Cycle | -2d ▲89.5% | -19d ▼90.0% | -10d ▲80.0% | -50d ▼28.2% | -39d ▼34.5% | -29d ▲37.0% | -46d ▼43.8% | -32d ▼633.3% | 6d ▼70.0% | 20d |
| Working Capital Days | -25d ▲28.6% | -35d ▲18.6% | -43d ▼72.0% | -25d ▲71.6% | -88d ▲37.1% | -140d ▲26.3% | -190d ▼1.6% | -187d ▼1.1% | -185d ▼18.6% | -156d |
| ROCE | 9.0% ▲28.6% | 7.0% ▼36.4% | 11.0% ▼67.6% | 34.0% ▲88.9% | 18.0% ▼28.0% | 25.0% ▲56.3% | 16.0% ▲420.0% | -5.0% ▼400.0% | -1.0% ▲97.7% | -44.0% |
Source: Screener.in · Lower days = better efficiency
About Ambalal Sarabhai Enterprises Limited
Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Ambalal Sarabhai Enterprises Limited share price today?▾
Ambalal Sarabhai Enterprises Limited (AMBALALSA) is currently trading at ₹31.48 on NSE, up 0.87% as of the last market session. Prices update daily after market close on MarketNetra.
Is Ambalal Sarabhai Enterprises Limited available in F&O (Futures & Options)?▾
Yes, Ambalal Sarabhai Enterprises Limited (AMBALALSA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Ambalal Sarabhai Enterprises Limited 52-week high and low?▾
Ambalal Sarabhai Enterprises Limited's 52-week high is ₹40.4 and the 52-week low is ₹23.1. The current price of ₹31.48 is 22.1% below the 52W high.
What is Ambalal Sarabhai Enterprises Limited P/E ratio?▾
Ambalal Sarabhai Enterprises Limited's current P/E ratio is 13.7. This indicates the market is paying ₹13.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Ambalal Sarabhai Enterprises Limited options?▾
Ambalal Sarabhai Enterprises Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade AMBALALSA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.